Blake Aftab's most recent trade in Adicet Bio Inc was a trade of 275,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 24 Jan 2025 | 6,270 | 56,241 | - | 0.9 | 5,780 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 336,911 | 336,911 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 241,173 | 241,173 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 19,700 | 62,511 | - | 0 | Common Stock | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.40 per share. | 24 Jan 2024 | 3,565 | 42,811 | - | 2.4 | 8,556 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 117,200 | 117,200 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 117,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 56,612 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 56,612 | 56,612 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 117,200 | 117,200 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 26,100 | 54,309 | - | 0 | Common Stock | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 10 Nov 2022 | 6,967 | 28,209 | - | 21 | 146,307 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.27 per share. | 19 Oct 2022 | 8,067 | 35,176 | - | 16.3 | 131,250 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.92 per share. | 12 Oct 2022 | 7,933 | 43,243 | - | 15.9 | 126,293 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2022 | 3,388 | 56,612 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.38 per share. | 12 Oct 2022 | 3,388 | 52,822 | - | 7.4 | 25,003 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.40 per share. | 12 Oct 2022 | 1,646 | 51,176 | - | 15.4 | 25,348 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 16,000 | 54,967 | - | 0 | Common Stock | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.25 per share. | 04 Aug 2022 | 5,533 | 49,434 | - | 18.2 | 100,977 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 03 Aug 2022 | 6,968 | 38,967 | - | 18 | 125,424 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.64 per share. | 01 Aug 2022 | 6,968 | 45,935 | - | 16.6 | 115,948 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.50 per share. | 05 Jul 2022 | 1,363 | 52,903 | - | 14.5 | 19,764 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 16,000 | 58,436 | - | 0 | Common Stock | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 14 Feb 2022 | 5,533 | 52,903 | - | 14.3 | 78,956 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 16,000 | 48,000 | - | 0 | Common Stock | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.69 per share. | 28 Jan 2022 | 5,564 | 42,436 | - | 11.7 | 65,043 | Common Stock |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2021 | 80,000 | 80,000 | - | 0 | Common Stock | |
| Adicet Bio Inc | Blake Aftab | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2021 | 60,000 | 60,000 | - | - | Stock Option (right to Buy) |